Greenberg B R, Woo L, Veomett I C, Payne C M, Ahmann F R
Section of Hematology/Oncology, Veterans Administration Medical Center, Tucson, Arizona 85723.
Br J Haematol. 1987 Aug;66(4):487-90. doi: 10.1111/j.1365-2141.1987.tb01332.x.
To determine the nature of the fibroblastic proliferation in myelofibrosis, we studied the cytogenetic composition of a pure population of in-vitro bone marrow fibroblastic cells (FC) from a patient with idiopathic chronic myelofibrosis who had trisomy 8 in her unstimulated peripheral blood cells. This cytogenetic abnormality was absent in all the FC studied supporting the premise that in the myeloproliferative disorders the myelofibrosis represents a secondary or non-neoplastic reaction to the clonal proliferation of haematopoietic stem cells.
为了确定骨髓纤维化中纤维母细胞增殖的性质,我们研究了一名特发性慢性骨髓纤维化患者体外骨髓纤维母细胞(FC)纯群体的细胞遗传学组成,该患者未受刺激的外周血细胞中有8号染色体三体。在所有研究的FC中均未发现这种细胞遗传学异常,这支持了以下前提:在骨髓增殖性疾病中,骨髓纤维化代表对造血干细胞克隆增殖的继发性或非肿瘤性反应。